Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma

被引:19
作者
Wu, W. [1 ]
Slomovitz, B. M. [1 ]
Soliman, P. T. [1 ]
Schmeler, K. M. [1 ]
Celestino, J. [1 ]
Milam, M. R. [1 ]
Lu, K. H. [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Unit 440, Houston, TX 77030 USA
关键词
cyclin D1; cyclin D3; endometrial cancer; PTEN;
D O I
10.1111/j.1525-1438.2006.00642.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclins D1 and D3 play key roles in cell cycle progression. The downregulation of cyclin D3 was associated with phosphatase and tensin homolog deleted on chromosome ten-(PTEN)-induced cell cycle arrest. We attempted to determine whether cyclin D1 and D3 overexpression is correlated with PTEN inactivation in endometrioid endometrial cancer (EEC). The expression of PTEN, cyclin D1, and cyclin D3 were determined by immunohistochemical analysis in 105 EEC specimens. Forty-three percent of the EEC demonstrated loss of PTEN expression. Cyclin D3 was overexpressed in only 18% of the EEC specimens and was not associated with tumor grade. Cyclin D1 was overexpressed in 64% of the specimens and was more common in moderate or high-grade tumors (P = 0.002 and P = 0.02, respectively). The overexpression of cyclin D3 was not correlated with loss of PTEN in the EEC. The overexpression of cyclin D1 was much higher in grade 1 tumors with negative PTEN than tumors with positive PTEN expression (67% vs 26%). The overexpression of cyclin D3 was neither frequent nor correlated with the loss of PTEN expression. The overexpression of cyclin D1 was higher in the low-grade tumors with negative PTEN expression than tumors with positive PTEN expression. Overexpression of cyclin D1 is frequent in moderate or high-grade EECs and likely results from multiple mechanisms.
引用
收藏
页码:1668 / 1672
页数:5
相关论文
共 35 条
[1]   Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27 [J].
An, HJ ;
Lee, YH ;
Cho, NH ;
Shim, JY ;
Kim, JY ;
Lee, C ;
Kim, SJ .
HISTOPATHOLOGY, 2002, 41 (05) :437-445
[2]   Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation [J].
Bartkova, J ;
Lukas, J ;
Strauss, M ;
Bartek, J .
ONCOGENE, 1998, 17 (08) :1027-1037
[3]   PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases [J].
Bussaglia, E ;
del Rio, E ;
Matias-Guiu, X ;
Prat, J .
HUMAN PATHOLOGY, 2000, 31 (03) :312-317
[4]   The multiple roles of PTEN in tumor suppression [J].
Di Cristofano, A ;
Pandolfi, PP .
CELL, 2000, 100 (04) :387-390
[5]   Cyclin D3 is rate-limiting for the G1/S phase transition in fibroblasts [J].
Henzinger, T ;
Reed, SI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (24) :14958-14961
[6]  
Ito K, 1998, ANTICANCER RES, V18, P1661
[7]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[8]   PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus [J].
Kimura, F ;
Watanabe, J ;
Hata, H ;
Fujisawa, T ;
Kamata, Y ;
Nishimura, Y ;
Jobo, T ;
Kuramoto, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (03) :161-168
[9]   PTEN1 is frequently mutated in primary endometrial carcinomas [J].
Kong, DH ;
Suzuki, A ;
Zou, TT ;
Sakurada, A ;
Kemp, LW ;
Wakatsuki, S ;
Yokoyama, T ;
Yamakawa, H ;
Furukawa, T ;
Sato, M ;
Ohuchi, N ;
Sato, S ;
Yin, J ;
Wang, SN ;
Abraham, JM ;
Souza, RF ;
Smolinski, KN ;
Meltzer, SJ ;
Horii, A .
NATURE GENETICS, 1997, 17 (02) :143-144
[10]   Cyclin D1 gene (CCND1) mutations in endometrial cancer [J].
Moreno-Bueno, G ;
Rodríguez-Perales, S ;
Sánchez-Estévez, C ;
Hardisson, D ;
Sarrió, D ;
Prat, J ;
Cigudosa, JC ;
Matias-Guiu, X ;
Palacios, J .
ONCOGENE, 2003, 22 (38) :6115-6118